Will People Accept a COVID-19 Vaccine? With Gretchen Chapman, PhD

Will People Accept a COVID-19 Vaccine? With G...

Up next

Tip or skip? What drives our tipping behavior, with Michael Lynn, PhD

Tipping has long been a part of service culture in the U.S., but in the last few years, the number of places where we're asked to tip has multiplied. Social psychologist and tipping researcher Michael Lynn, PhD, discusses “tip creep” and how digital payment screens are reshaping ...  Show more

The psychology of spending, debt and budgeting, with Abigail Sussman, PhD

Buy now, pay later plans have skyrocketed in popularity in recent years, adding yet another variable to consider when making spending decisions. Abigail Sussman, PhD, discusses the psychological biases that influence how we spend, budget and borrow, including why splitting paymen ...  Show more

Recommended Episodes

COVID-19 Chapter 13: Vaccines, Take 2
This Podcast Will Kill You

We’re back with another episode in our Anatomy of a Pandemic series on COVID-19. This time, our subject matter is the one everyone has been waiting for: vaccines. In this episode, with the help of two amazing guests, we attempt to answer all of your burning questions about the ...

  Show more

Our Vaccine Expectations Are Unrealistic
Prognosis: Misconception

In the fight against COVID-19, so many are pinning their hopes on a vaccine. But how long will it take? Russia’s super-fast-tracked COVID-19 one is technically the first in the world. But the first vaccine may not be the best one. And even with other vaccine trials underway aroun ...  Show more

Addressing Vaccine Skepticism
Chasing Life

An alarming number of Americans hold negative views about vaccination. So if and when we get a Covid-19 vaccine, will people sign up to receive it? CNN’s Chief Medical Correspondent Dr. Sanjay Gupta talks with vaccine scientist Dr. Peter Hotez about the safety of vaccines. To lea ...  Show more

What We Can't Know About a Vaccine
Prognosis: Misconception

The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ...  Show more